New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy – News-Medical.net
News-Medical.net |
New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy
News-Medical.net Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don't respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied to how primed patients' immune systems are … |
